Tech Company Financing Transactions

Vergent Bioscience Funding Round

Orlando Health, Colle Capital and Intuitive Surgical joined a $21.5 million Series B funding round for Vergent Bioscience. This VC investment round was announced on 10/4/2022.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

5810 W 78th St. 222
Minneapolis, MN 55439
USA

Phone

Undisclosed

Website

www.vergentbio.com

Email Address

[email protected]

Overview

Vergent is a biotechnology company developing a tumor-targeted, fluorescent probe to help surgeons quickly identify and completely remove cancerous tissue during surgery. Surgery is often the first-line treatment for solid tumors and the prognosis of a procedure is highly correlated with achieving complete tumor removal.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

John Santini

        

Browse more venture capital transactions:

Prev: 10/4/2022: Sibylla Biotech venture capital transaction
Next: 10/4/2022: Katalyst venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary